{"id":2049,"name":"Psymed Ventures","slug":"psymed-ventures","website":"https://psymed.ventures/","hqGeo":"New York, NY","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other"],"excludedSectors":[],"checkSizeMin":250000,"checkSizeMax":2000000,"thesisSummary":"Psymed Ventures invests in companies at the frontier of mental health and neuroscience, with a strong emphasis on psychedelic medicine.","thesisNarrative":null,"logoUrl":null,"aumUsd":30000000,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Journey Clinical","companyUrl":null,"stage":null,"sector":"Psychedelic Therapy","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Delix Therapeutics","companyUrl":null,"stage":null,"sector":"Neuropsychiatry","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"AERSKA","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Regenerative medicine for Alzheimer's and beyond","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ALTO NEUROSCIENCE","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Precision psychiatry drug development platform","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ANCILIA","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"CRISPR for live biotherapeutics and bacterial products","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ATAI LIFE SCIENCES","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Neuro drug development platform with 10+ programs","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"BECKLEY PSYTECH","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Drug development platform focused neurological and psychiatric disorders","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"BEXSON BIOMEDICAL","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Novel ketamine formulations for pain management and mental health disorders","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"BLOOM SCIENCE","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Microbiome therapeutics platform for neurological disease","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"BRIGHT MINDS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Creating the next generation of psychedelics to treat mental health and other CNS disorders","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"DELIX THERAPUTICS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Non-hallucinogenic versions of psychedelic compounds with favorable safety and efficacy","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"FREEDOM BIOSCIENCES","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Next generation ketamine & psychedelic therapeutics","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"GILGAMESH PHARMACEUTICALS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Clinical stage neuroscience biotech developing innovative new chemical entities","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"HUMANS ANONYMOUS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Anonymous audio spaces for mental health","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"IMYOO","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Patient-centric immune biodiscovery platform","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"IRIS MEDICINE","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Small-binding RNA medicine for neurodegenerative diseases","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"JIMINI HEALTH","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"AI-assisted therapy tool for therapists","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"MAYA HEALTH","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Patient management and data intelligence platform for psychedelic therapy","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"MINDSTATE DESIGN LABS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Next generation psychedelic-inspired therapeutics for mental health conditions","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"MOTIF NEUROTECH","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Minimally invasive bioelectronic solutions for TRD","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NEURODE","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Non invasive neurostimulation and monitoring platform, starting with ADHD","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"REMEPY","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Hybrid treatments combining traditional drugs with digital therapeutics","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"RESET PHARMA","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Novel psychedelic treatments for patients with life-threatening illnesses","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"SANMAI","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Transcranial focused ultrasound for mental health","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"SCULPTA BIO","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Programmable RNA splicing medicine for complex brain diseases","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"TACTOGEN","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Drug development platform for gentler and safer entactogens","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"TERRAN","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Drug discovery platform for CNS and mental health","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"TRIPP","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"VR/AR platform for meditation and psychedelic-like experiences","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"STEALTH MARKETPLACE","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Marketplace for transformational mental health modalities","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"STEALTH NEUROTECH","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Biohybrid brain-computer interfaces","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"STEALTH BIOTECH","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Virtual organelle ML models","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"STEALTH HEALTHCARE","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Integrated solution for cancer-specific behavioral health","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":6,"partners":[{"id":18711,"name":"Matias Serebrinsky","title":"General Partner","seniority":null,"focusTags":["Mental & brain health","Frontier neurotechnology","Psychedelics","Precision psychiatry"],"linkedinUrl":"https://www.linkedin.com/in/matiasserebrinsky","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":18712,"name":"Greg Kubin","title":"General Partner","seniority":null,"focusTags":["Mental & brain health","Community building","Digital therapeutics","Alternative modalities"],"linkedinUrl":"https://www.linkedin.com/in/gregkubin","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":18713,"name":"Dina Burkitbayeva","title":"General Partner","seniority":null,"focusTags":["Psychedelic medicine therapeutics","Neuropsychiatric drug development","Innovation in mental health treatments"],"linkedinUrl":"https://www.linkedin.com/in/dinaburkitbayeva","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":18714,"name":"Brooks Leitner, MD-PhD","title":"Partner","seniority":null,"focusTags":["Clinical neuroscience","Translational science","Neurobiology","Mental health biotech"],"linkedinUrl":"https://www.linkedin.com/in/brooksleitner","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":18715,"name":"Tim Gardner, PhD","title":"Partner","seniority":null,"focusTags":["Neurotechnology","Bioengineering","Academic-industry translation"],"linkedinUrl":"https://www.linkedin.com/in/timgardnerphd","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":18716,"name":"Negin Mohktari, PhD","title":"Partner","seniority":null,"focusTags":["Biotechnology investment","Therapeutics","Early-stage life sciences"],"linkedinUrl":"https://www.linkedin.com/in/neginmohktari","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":"cold outreach ok","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":8445,"name":"Thrive River Partners","slug":"thrive-river-partners","logoUrl":null,"website":"https://www.trivecapital.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other"],"hqGeo":"Portland, OR"},{"id":8487,"name":"Vital Mind Ventures","slug":"vital-mind-ventures","logoUrl":null,"website":"https://www.vitalventures.live/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Healthcare","Other"],"hqGeo":"London, UK"},{"id":8377,"name":"Pathfind Wellness Investments","slug":"pathfind-wellness-investments","logoUrl":null,"website":"https://www.pathfinderwc.com/","stageFocus":["Seed","Series A"],"sectorTags":["Healthcare","Other"],"hqGeo":"Denver, CO"},{"id":9842,"name":"TheraBridge Ventures","slug":"therabridge-ventures","logoUrl":null,"website":null,"stageFocus":["Pre-Seed"],"sectorTags":["Other","Healthcare"],"hqGeo":"Boston, MA"},{"id":8757,"name":"HeartMind Ventures","slug":"heartmind-ventures","logoUrl":null,"website":null,"stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other","Healthcare"],"hqGeo":"Boston, MA"},{"id":8619,"name":"WellMind Seed Fund","slug":"wellmind-seed-fund","logoUrl":null,"website":"https://wellmind.com","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Healthcare","Other","Marketplace"],"hqGeo":"London, UK"}],"featuredIn":[{"slug":"pre-seed","displayName":"Pre-Seed Investors","pageType":"stage"},{"slug":"seed","displayName":"Seed Investors","pageType":"stage"}],"fundraisingResources":[{"slug":"find-right-pre-seed-investors-b2b-saas","title":"How to Find the Right Pre-Seed Investors for Your B2B SaaS Startup"},{"slug":"Finding-Investors-For-Startup-In-2026","title":"How to Find Investors for Your Startup in 2026 (Without Cold-Searching Databases)"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-06-13T08:11:23.079Z"}